Noramco, a US producer of active pharmaceutical ingredients (APIs), has announced the launch of Noramco Group as an integrated North American-based API and drug product...
Noramco, a US producer of active pharmaceutical ingredients (APIs), has completed the acquisition of the Cambrex drug product business unit previously known as Halo...
18.03.2018
- Noramco, a global leading producer of controlled substances for the pharmaceutical industry, and AMPAC Fine Chemicals (AFC), a major manufacturer of Active Pharmaceutical...
